![Combined treatment of anogenital HPV infection with cryodestruction, podophyllin 25% and post-ablation immunomodulation with sinecatechins 15% ointment – a retrospective analysis | Semantic Scholar Combined treatment of anogenital HPV infection with cryodestruction, podophyllin 25% and post-ablation immunomodulation with sinecatechins 15% ointment – a retrospective analysis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6805ed95fca627fac861cb1638b616ea868b32d8/3-Figure1-1.png)
Combined treatment of anogenital HPV infection with cryodestruction, podophyllin 25% and post-ablation immunomodulation with sinecatechins 15% ointment – a retrospective analysis | Semantic Scholar
![A Single-Blinded Randomized Controlled Study to Assess the Efficacy of Twice Daily Application of Sinecatechins 15% Ointment When Used Sequentially With Cryotherapy in the Treatment of External Genital Warts - JDDonline - A Single-Blinded Randomized Controlled Study to Assess the Efficacy of Twice Daily Application of Sinecatechins 15% Ointment When Used Sequentially With Cryotherapy in the Treatment of External Genital Warts - JDDonline -](http://dl.jddonline.com/articleimages/article_2617/table1.png)
A Single-Blinded Randomized Controlled Study to Assess the Efficacy of Twice Daily Application of Sinecatechins 15% Ointment When Used Sequentially With Cryotherapy in the Treatment of External Genital Warts - JDDonline -
![Molecules | Free Full-Text | Applications of a Standardized Green Tea Catechin Preparation for Viral Warts and Human Papilloma Virus-Related and Unrelated Cancers Molecules | Free Full-Text | Applications of a Standardized Green Tea Catechin Preparation for Viral Warts and Human Papilloma Virus-Related and Unrelated Cancers](https://www.mdpi.com/molecules/molecules-25-02588/article_deploy/html/images/molecules-25-02588-g001.png)
Molecules | Free Full-Text | Applications of a Standardized Green Tea Catechin Preparation for Viral Warts and Human Papilloma Virus-Related and Unrelated Cancers
NDA 21-902 VEREGEN (sinecatechins) Ointment, 15% Rx Only For Topical Dermatologic Use Only Not for Ophthalmic, Oral, Intravagina
![These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006 These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=veregen-01.jpg&id=581570)
These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006
![These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006 These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=veregen-02.jpg&id=581570)